GRM Overseas is currently trading at Rs. 163.70, up by 1.95 points or 1.21% from its previous closing of Rs. 161.75 on the BSE.

The scrip opened at Rs. 162.30 and has touched a high and low of Rs. 165.70 and Rs. 161.90 respectively. So far 17234 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 185.55 on 24-Dec-2025 and a 52 week low of Rs. 88.28 on 02-Jun-2025.

Last one week high and low of the scrip stood at Rs. 170.00 and Rs. 156.10 respectively. The current market cap of the company is Rs. 3383.74 crore.

The promoters holding in the company stood at 62.51%, while Institutions and Non-Institutions held 12.41% and 25.08% respectively.

GRM Overseas has launched 10X Basmati Rice Suitable for Diabetics. The product will be rolled out across key International and Domestic markets, marking an important step in GRM’s strategy to expand its health-focused product portfolio globally.

This new launch addresses the rising demand for healthier dietary choices on account of rising diabetes prevalence, urban lifestyles, and health awareness across markets. The 10X Basmati Rice suitable for Diabetics combines the aroma, elongation, and taste of premium basmati rice with carefully processed characteristics aimed at supporting better glycaemic management, making it a suitable choice for people seeking healthier, diabetic-friendly products with low GI and high fibre, without compromising on quality or taste.

This launch reinforces GRM’s long-term vision of evolving from a traditional rice exporter into a well diversified, consumer-centric food company, offering products that address modern lifestyle needs while maintaining the highest standards of quality and consistency.

GRM Overseas is presently engaged in the business of processing and sale of rice.